Aethlon Medical Amends Offering to Raise $3.3M Net, Facing Over 400% Potential Dilution
AEMD is trading near its 52-week low of $0.78 (12% above the low).
Summary
Aethlon Medical filed an amended S-1 for a best-efforts offering of common stock and warrants, seeking $3.3 million in net proceeds at $0.85 per unit, which could lead to over 400% dilution for existing shareholders.
Key Events · Financing and Capital Events · AEMD
-
Capital Raise Details
The company is offering up to 4,705,882 shares of common stock and an equal number of accompanying warrants at a combined price of $0.85 per unit. Net proceeds are estimated at $3.335 million.
-
Extreme Potential Dilution
If all shares and warrants from this offering are issued and exercised, it could result in the issuance of approximately 9.6 million new shares, representing over 400% dilution compared to the current 2.37 million outstanding shares.
-
Going Concern & Nasdaq Risk
This offering is crucial for the company's survival, as it recently reported substantial doubt about its ability to continue as a going concern. The offering price of $0.85 per share does not help address the ongoing Nasdaq minimum bid price deficiency.
-
Best-Efforts Offering
The offering is on a "best-efforts" basis with no minimum amount required to be sold, meaning the company may not raise the full target amount.
Analysis · AEMD · Industrial Applications And Services
This S-1 amendment details a best-efforts offering of common stock and warrants, aiming to raise approximately $3.3 million in net proceeds. The offering is priced at $0.85 per unit, which is at the market price of June 29, 2026, and below today's price. This capital raise is critical for the company, which recently disclosed substantial doubt about its ability to continue as a going concern. However, the offering could result in over 400% potential dilution if all shares and warrants are issued and exercised, severely impacting existing shareholders. The company also faces Nasdaq delisting risk due to its share price trading below $1.00, a problem not addressed by this offering's pricing.
At the time of this filing, AEMD was trading at $0.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2M. The 52-week trading range was $0.78 to $27.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.